Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Gains from Investment Securities (2016 - 2025)

Medicure has reported Gains from Investment Securities over the past 12 years, most recently at $369299.4 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 184.99% year-over-year to $369299.4; the TTM value through Dec 2025 reached -$129888.9, up 74.31%, while the annual FY2025 figure was -$129075.5, 1.87% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $369299.4 at Medicure, up from $263041.9 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $391386.0 in Q2 2022 and troughed at -$1.0 million in Q4 2021.
  • A 5-year average of -$100653.2 and a median of -$20302.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 581.1% in 2022 and later crashed 2012.71% in 2024.
  • Year by year, Gains from Investment Securities stood at -$1.0 million in 2021, then soared by 103.11% to $32414.9 in 2022, then plummeted by 163.45% to -$20567.0 in 2023, then crashed by 2012.71% to -$434520.4 in 2024, then soared by 184.99% to $369299.4 in 2025.
  • Business Quant data shows Gains from Investment Securities for MCUJF at $369299.4 in Q4 2025, $263041.9 in Q3 2025, and -$744807.3 in Q2 2025.